Takeda Pharmaceutical
310 hedge funds and large institutions have $1.32B invested in Takeda Pharmaceutical in 2023 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 90 increasing their positions, 97 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.2% less ownership
Funds ownership: 5.5% → 5.31% (-0.2%)
4% less capital invested
Capital invested by funds: $1.38B → $1.32B (-$60.3M)
7% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 97
Holders
310
Holding in Top 10
6
Calls
$44.7M
Puts
$5.98M
Top Buyers
| 1 | +$20.1M | |
| 2 | +$14.8M | |
| 3 | +$13.6M | |
| 4 |
Renaissance Technologies
New York
|
+$10.6M |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$9.05M |
Top Sellers
| 1 | -$51.3M | |
| 2 | -$25.7M | |
| 3 | -$24.9M | |
| 4 |
Millennium Management
New York
|
-$11.9M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$10.7M |